Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Nature 468, 187193
Patients with Co-morbid Conditions: Those with other chronic conditions, such as diabetes, hypertension, or cardiovascular disease, should be evaluated carefully
CONTRAINDICATIONS According to the package insert, Wegovy is contraindicated in patients with the following: personal or family history of Medullary Thyroid Carcinoma patients with Multiple Endocrine Neoplasm type 2 patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Wegovy
Additional documentation may show that you qualify
Both product lines must comply with CMS formulary requirements under 42 CFR Part 423, which mandate that Part D sponsors cover at least two drugs in most therapeutic categories
US$ 25.37
US$ 27.61
US$ 25.88
